Vantis Vascular

Vantis Vascular is a medical technology company based in San Jose, California, founded by physicians with a mission to enhance vascular interventions. The company develops performance-driven technologies aimed at improving the speed, safety, and effectiveness of treatments for complex vascular anatomies, particularly in high-risk coronary and peripheral interventions. Their flagship product, the CrossFAST Integrated Microcatheter Advanced Delivery System, is the first dual monorail microcatheter system designed specifically for challenging vascular cases. It features patented DuoPro™ Interlocking Technology, which enhances pushability and deliverability in difficult anatomies, achieving 100% procedural success in complex high-risk coronary interventions. Vantis Vascular is also developing the CrossSHOCK Intravascular Lithotripsy System to further advance their offerings. Vantis Vascular primarily serves interventional cardiologists and vascular specialists, focusing on improving procedural efficiency and safety for patients with multiple comorbidities. The company is actively commercializing the CrossFAST system in the U.S., with plans for a full market release in 2025.

• Employees 13